rs62637631

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000264.5(PTCH1):​c.4080C>T​(p.Ser1360Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00622 in 1,613,082 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S1360S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0041 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0065 ( 34 hom. )

Consequence

PTCH1
NM_000264.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:17

Conservation

PhyloP100: -0.0740

Publications

7 publications found
Variant links:
Genes affected
PTCH1 (HGNC:9585): (patched 1) This gene encodes a member of the patched family of proteins and a component of the hedgehog signaling pathway. Hedgehog signaling is important in embryonic development and tumorigenesis. The encoded protein is the receptor for the secreted hedgehog ligands, which include sonic hedgehog, indian hedgehog and desert hedgehog. Following binding by one of the hedgehog ligands, the encoded protein is trafficked away from the primary cilium, relieving inhibition of the G-protein-coupled receptor smoothened, which results in activation of downstream signaling. Mutations of this gene have been associated with basal cell nevus syndrome and holoprosencephaly. [provided by RefSeq, Aug 2017]
PTCH1 Gene-Disease associations (from GenCC):
  • basal cell nevus syndrome 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • holoprosencephaly 7
    Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nevoid basal cell carcinoma syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen
  • holoprosencephaly
    Inheritance: AD Classification: LIMITED Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 9-95447176-G-A is Benign according to our data. Variant chr9-95447176-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 92698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.074 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00406 (618/152360) while in subpopulation NFE AF = 0.00709 (482/68028). AF 95% confidence interval is 0.00656. There are 2 homozygotes in GnomAd4. There are 294 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 618 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000264.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTCH1
NM_000264.5
MANE Select
c.4080C>Tp.Ser1360Ser
synonymous
Exon 23 of 24NP_000255.2Q13635-1
PTCH1
NM_001083603.3
MANE Plus Clinical
c.4077C>Tp.Ser1359Ser
synonymous
Exon 23 of 24NP_001077072.1Q13635-2
PTCH1
NM_001354918.2
c.3924C>Tp.Ser1308Ser
synonymous
Exon 22 of 23NP_001341847.1A0A1W5YLI7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTCH1
ENST00000331920.11
TSL:5 MANE Select
c.4080C>Tp.Ser1360Ser
synonymous
Exon 23 of 24ENSP00000332353.6Q13635-1
PTCH1
ENST00000437951.6
TSL:5 MANE Plus Clinical
c.4077C>Tp.Ser1359Ser
synonymous
Exon 23 of 24ENSP00000389744.2Q13635-2
PTCH1
ENST00000429896.6
TSL:1
c.3627C>Tp.Ser1209Ser
synonymous
Exon 23 of 24ENSP00000414823.2Q13635-4

Frequencies

GnomAD3 genomes
AF:
0.00406
AC:
618
AN:
152242
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00149
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00196
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.000771
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00198
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00707
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00397
AC:
981
AN:
246966
AF XY:
0.00390
show subpopulations
Gnomad AFR exome
AF:
0.000980
Gnomad AMR exome
AF:
0.00223
Gnomad ASJ exome
AF:
0.000603
Gnomad EAS exome
AF:
0.000383
Gnomad FIN exome
AF:
0.00194
Gnomad NFE exome
AF:
0.00715
Gnomad OTH exome
AF:
0.00396
GnomAD4 exome
AF:
0.00645
AC:
9423
AN:
1460722
Hom.:
34
Cov.:
30
AF XY:
0.00625
AC XY:
4543
AN XY:
726670
show subpopulations
African (AFR)
AF:
0.00114
AC:
38
AN:
33478
American (AMR)
AF:
0.00244
AC:
109
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.000919
AC:
24
AN:
26116
East Asian (EAS)
AF:
0.000353
AC:
14
AN:
39698
South Asian (SAS)
AF:
0.000870
AC:
75
AN:
86256
European-Finnish (FIN)
AF:
0.00208
AC:
109
AN:
52424
Middle Eastern (MID)
AF:
0.00173
AC:
10
AN:
5768
European-Non Finnish (NFE)
AF:
0.00791
AC:
8792
AN:
1111898
Other (OTH)
AF:
0.00417
AC:
252
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
701
1402
2102
2803
3504
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
334
668
1002
1336
1670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00406
AC:
618
AN:
152360
Hom.:
2
Cov.:
32
AF XY:
0.00395
AC XY:
294
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.00149
AC:
62
AN:
41594
American (AMR)
AF:
0.00196
AC:
30
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.000773
AC:
4
AN:
5174
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4832
European-Finnish (FIN)
AF:
0.00198
AC:
21
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00709
AC:
482
AN:
68028
Other (OTH)
AF:
0.00473
AC:
10
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
33
67
100
134
167
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00531
Hom.:
0
Bravo
AF:
0.00399
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.00703
EpiControl
AF:
0.00818

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
5
not specified (5)
-
-
3
Gorlin syndrome (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Holoprosencephaly 7 (1)
-
-
1
Holoprosencephaly 7;C2751544:Basal cell carcinoma, susceptibility to, 1;CN376810:Basal cell nevus syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
6.0
DANN
Benign
0.72
PhyloP100
-0.074
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62637631; hg19: chr9-98209458; COSMIC: COSV59496118; API